Quality Consistency Evaluation of Traditional Chinese Medicines: Current Status and Future Perspectives

被引:0
|
作者
Liu, Chun-Lu [1 ]
Jiang, Yan [2 ]
Li, Hui-Jun [1 ]
机构
[1] China Pharmaceut Univ, State Key Lab Nat Med, 639 Longmian Rd, Nanjing 211198, Peoples R China
[2] Nanjing Forestry Univ, Coll Chem Engn, 159 Longpan Rd, Nanjing 210037, Peoples R China
关键词
Biology-based strategy; chemistry-based strategy; chemistry-biology strategy; quality consistency; traditional Chinese medicines (TCMs); CHEMICAL STANDARDIZATION APPROACH; METABOLIC-ACTIVITY; FINGERPRINT METHOD; DISSOLUTION; HPLC; STRATEGY; BIOASSAY; MARKERS; TABLETS; PILL;
D O I
10.1080/10408347.2024.2305267
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Quality consistency evaluation of traditional Chinese medicines (TCMs) is a crucial factor that determines the safe and effective application in clinical settings. However, TCMs exhibit diverse, heterogeneous, complex, and flexible chemical compositions, as well as variability in preparation processes. These characteristics pose greater challenges in researching the consistency of TCMs compared to chemically synthesized and biological drugs. Therefore, it is paramount to develop effective strategies for evaluating the quality consistency of TCMs. From the starting point of quality properties, this review explores the strategy used to evaluate quality consistency in terms of chemistry-based strategy (chemical consistency) and the biology-based strategy (bioequivalence). Among them, the chemistry-based strategy is the mainstream, and biology-based strategy complements the chemistry-based strategy each other. Furthermore, the emerging chemistry-biology strategies (overall evaluation) is discussed, including individually combining strategy and integration strategy. Finally, this review provides insights into the challenges and future perspectives in this field. By highlighting current status and trends in TCMs quality consistency, this review aims to contribute to establishment of generally applicable chemistry-biology integrated evaluation strategy for TCMs. This will facilitate the advancement toward a higher stage of overall quality evaluation.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Current Status and Future Perspective in the Globalization of Traditional Chinese Medicines
    Wan-Ying Wu
    Wen-Zhi Yang
    Jin-Jun Hou
    De-An Guo
    World Journal of Traditional Chinese Medicine, 2015, 1 (01) : 1 - 4
  • [2] Discovery of quality control markers from traditional Chinese medicines by fingerprint-efficacy modeling: Current status and future perspectives
    Zhang, Cai
    Zheng, Xian
    Ni, Hui
    Li, Ping
    Li, Hui-Jun
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2018, 159 : 296 - 304
  • [3] Traditional Chinese herbal injection: Current status and future perspectives
    Li, Haona
    Wang, Siwang
    Yue, Zhihua
    Ren, Xuequn
    Xia, Jielai
    FITOTERAPIA, 2018, 129 : 249 - 256
  • [4] Current role and future perspectives of chemometrics in spectroscopic and chromatographic analysis of traditional Chinese medicines
    Dai, Linghao
    Guan, Yang
    Wang, Bo
    Wang, Linyan
    MATERIALS EXPRESS, 2022, 12 (02) : 202 - 213
  • [5] Traditional medicines and globalization: current and future perspectives in ethnopharmacology
    Leonti, Marco
    Casu, Laura
    FRONTIERS IN PHARMACOLOGY, 2013, 4
  • [6] Cancer Pain Management with Traditional Chinese Medicine: Current Status and Future Perspectives
    Ji, Jiafu
    Guo, Jingxuan
    Chi, Yongliang
    Su, Fan
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2024, 52 (01): : 123 - 135
  • [7] Quality evaluation of traditional Chinese medicines based on fingerprinting
    Liu, Xiaoyan
    Jiang, Wenwen
    Su, Mei
    Sun, Yue
    Liu, Hongming
    Nie, Lei
    Zang, Hengchang
    JOURNAL OF SEPARATION SCIENCE, 2020, 43 (01) : 6 - 17
  • [8] The current status and the future of traditional Chinese Medicine in Taiwan
    Lai, MS
    TOWARDS NATURAL MEDICINE RESEARCH IN THE 21ST CENTURY, 1998, 1157 : 151 - 160
  • [9] The interactions between traditional Chinese medicine and gut microbiota in cancers: Current status and future perspectives
    Wei, Xuejiao
    Wang, Fei
    Tan, Peng
    Huang, Huiming
    Wang, Zhuguo
    Xie, Jinxin
    Wang, Longyan
    Liu, Dongxiao
    Hu, Zhongdong
    PHARMACOLOGICAL RESEARCH, 2024, 203